家禽疫苗市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Poultry Vaccines Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月02日 | 出版商:

Global Market Insights Inc. | 英文 195 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球家禽疫苗市場價值為 23 億美元，預計 2024 年至 2032 年複合年成長率為 7.1%。成長和蛋白質消耗量的增加。特別是在新興經濟體，向富含蛋白質的飲食的轉變刺激了對家禽養殖的投資，進一步增加了對有效疾病預防措施（尤其是動物疫苗）的需求。

糧食及農業組織 (FAO) 和經濟合作暨發展組織 (OECD) 的預測強調，家禽產品的需求不斷成長是主要的市場驅動力。他們預測，未來十年全球禽肉消費量將成長 15%，預計到 2032 年將達到 9,100 萬噸。

整個產業分為產品、疾病類型、應用、劑型、最終用戶和地區。

依產品細分，市場包括減毒活疫苗、去活化疫苗、重組疫苗等類型。減毒活疫苗在全球家禽疫苗市場佔據主導地位，預計在預測期內將以 6.9% 的速度成長。減毒活疫苗引領市場，因其能引發強大且持久的免疫反應而受到青睞。它們提供快速的免疫力，對於保護幼鳥和迅速應對疫情至關重要。它們具有成本效益且適應性強，其生產和管理通常需要較少的劑量，這使其成為大規模家禽養殖的理想選擇。

依疾病類型細分，家禽疫苗產業包括新城疫、傳染性支氣管炎、傳染性法氏囊病、沙門氏菌、馬立克氏症、滴蛋症候群、腺病毒、球蟲病、禽流感、傳染性喉氣管炎、禽腦脊髓炎等。 2023 年，新城疫細分市場佔最大市場佔有率，達到 20.8%。疫情導致巨大的經濟損失，表現為死亡率升高、產蛋量減少和生長速度遲緩，往往導致受影響鳥類的撲殺增加。這種財務影響放大了家禽業對有效疫苗的需求。

北美引領全球家禽疫苗市場，預計將以7% 的速度成長，到2032 年估值將達到17 億美元。。作為疫苗開發創新中心，北美在疫苗功效和給藥方法方面的持續研究和進步將增強其市場成長潛力。

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 11 章：公司簡介

Biovac
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Dechra Pharmaceuticals PLC
Elanco Animal Health Incorporated
Hester Biosciences Limited
HIPRA
Merck and Co., Inc.
Phibro Animal Health Corporation
Vaxxinova International BV
Venky's Limited
Zoetis, Inc.

簡介目錄

Product Code: 10613

The Global Poultry Vaccines Market was valued at USD 2.3 billion in 2023 and is projected to grow at a CAGR of 7.1% from 2024 to 2032. This growth is driven by increasing global demand for poultry products, such as meat and eggs, fueled by population growth and rising protein consumption. Particularly in emerging economies, the shift towards protein-rich diets has spurred investments in poultry farming, further amplifying the need for effective disease prevention measures, notably animal vaccines.

Projections from the Food and Agriculture Organization (FAO) and the Organization for Economic Co-operation and Development (OECD) underscore the rising demand for poultry products as a key market driver. Their forecasts indicate a 15% growth in global poultry meat consumption over the next decade, estimating a reach of 91 million tons by 2032.

The overall industry is divided into product, disease type, application, dosage form, end-user, and region.

Segmented by product, the market includes attenuated live vaccines, inactivated vaccines, recombinant vaccines, and other types. Dominating the global poultry vaccines market, attenuated live vaccines are projected to grow at 6.9% during the forecast period. Leading the market, attenuated live vaccines are favored for their ability to elicit a robust and enduring immune response. They provide a swift immunity onset, vital for safeguarding young birds and addressing outbreaks promptly. Cost-effective and adaptable, their production and administration often require fewer doses, making them ideal for extensive poultry operations.

Segmented by disease type, the poultry vaccines industry encompasses Newcastle disease, infectious bronchitis, infectious bursal diseases, salmonella, Marek's disease, egg drop syndrome, adenovirus, coccidiosis, avian influenza, infectious laryngotracheitis, avian encephalomyelitis, among others. In 2023, the Newcastle disease segment held the largest market share at 20.8%. Outbreaks lead to substantial economic losses, manifesting as elevated mortality rates, diminished egg production, and stunted growth rates, often resulting in increased culling of affected birds. Such financial repercussions amplify the demand for effective vaccines in the poultry sector.

North America led the global poultry vaccines market and is projected to grow at 7%, aiming for a valuation of USD 1.7 billion by 2032. With its advanced farming practices and technologies, North America's poultry industry, especially in the U.S. and Canada, boasts sophisticated vaccination programs and stringent biosecurity measures, underpinning the regional market growth. As a center for vaccine development innovation, North America's continuous research and advancements in vaccine efficacy and delivery methods will bolster its market growth potential.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising demand for poultry products
  - 3.2.1.2 Increased outbreaks of poultry diseases
  - 3.2.1.3 Technological advancements in vaccine development
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost associated with vaccine development and production
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Attenuated live vaccines
5.3 Inactivated vaccines
5.4 Recombinant vaccines
5.5 Other vaccine types

Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Newcastle disease
6.3 Infectious bronchitis
6.4 Infectious bursal diseases
6.5 Salmonella
6.6 Marek's disease
6.7 Egg drop syndrome
6.8 Adenovirus
6.9 Coccidiosis
6.10 Avian influenza
6.11 Infectious laryngotracheitis
6.12 Avian encephalomyelitis
6.13 Other disease types

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Breeder
7.3 Layer
7.4 Broiler

Chapter 8 Market Estimates and Forecast, By Dosage Form, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Liquid vaccine
8.3 Freeze dried vaccine

Chapter 9 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Veterinary hospitals and clinics
9.3 Poultry farms

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa